Know Cancer

or
forgot password
  • cancer clinical trials in johnson city, TN

  • Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Breast Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Leukemia
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Leukemia
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Kidney Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    East Tennessee State University
    Johnson City, Tennessee 37614-0054
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    East Tennessee State University
    Johnson City, Tennessee 37614-0054
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    Cooperative Appalachian Marrow Program
    Johnson City, Tennessee 37604
    Healthy
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Neuroblastoma
    Phase 3 Papulopustular Rosacea Study
    TriCities Skin and Cancer
    Johnson City, Tennessee 37604
    Papulopustular Rosacea (PPR)
    A Twelve Week Safety and Efficacy Study in Rosacea
    TriCities Skin and Cancer
    Johnson City, Tennessee 37604
    Papulopustular Rosacea
    An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
    East Tennessee State University
    Johnson City, Tennessee 37614-0054
    Skin Cancer
    Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Brain and Central Nervous System Tumors
    Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Kidney Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Kidney Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Sarcoma
    Combination Chemotherapy in Treating Children With Neuroblastoma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Neuroblastoma
    Surgery in Treating Children With Neuroblastoma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Neuroblastoma
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Leukemia
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Brain and Central Nervous System Tumors
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Brain and Central Nervous System Tumors
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Sarcoma
    Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Cardiac Toxicity, Sarcoma
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia
    Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Leukemia, Lymphoma
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Sarcoma
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    James H. Quillen College of Medicine
    Johnson City, Tennessee 37614-0622
    Leukemia
    Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
    MultiSpecialty Clinical Research
    Johnson City, Tennessee 37601
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Lobradimil and Carboplatin in Treating Children With Brain Tumors
    East Tennessee State University Cancer Center at JCMC
    Johnson City, Tennessee 37604
    Brain and Central Nervous System Tumors
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia
    Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Brain and Central Nervous System Tumors
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Leukemia
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    East Tennessee State University Cancer Center at Johnson City Medical Center
    Johnson City, Tennessee 37604
    Cervical Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    McLeod Cancer & Blood Center
    Johnson City, Tennessee 37604
    Lung Cancer, Non-small-cell Lung Carcinoma
    Non-small Cell Lung Cancer Registry
    McLeod Cancer & Blood Center
    Johnson City, Tennessee 37604
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
    McLeod Cancer and Blood Center
    Johnson City, Tennessee 37604
    Myelodysplastic Syndromes
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    McLeod Cancer and Blood Center
    Johnson City, Tennessee 37604
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
    Johnson City Medical Center Hospital
    Johnson City, Tennessee 37604
    Head and Neck Cancer, Mucositis, Pain, Radiation Toxicity
    Phase I Trial of Docetaxel With Perifosine
    Investigative Site
    Johnson City, Tennessee 37604
    Neoplasms
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    McLeod Cancer and Blood Center
    Johnson City, Tennessee 37604
    Prostate Cancer
    Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    East Tennessee State University
    Johnson City, Tennessee 37614-0054
    Head and Neck Cancer
    A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
    McLeod Cancer & Blood Center
    Johnson City, Tennessee 37604
    Extensive-stage Small Cell Lung Cancer
    rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study
    East Tennessee Brain & Spine
    Johnson City, Tennessee 37604
    Degenerative Disc Disease
    Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
    McLeod Cancer and Blood Center
    Johnson City, Tennessee 37604
    Fatigue, Chemotherapy Side Effects